June 2026
The global immunology biosimilars market size was estimated at USD 11.23 billion in 2025 and is expected to hit around USD 56.39 billion by 2035, growing at a CAGR of 17.51%.
September 2026
The global biosimilars market size is exhibited at USD 47.36 billion in 2026 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.
September 2026
The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 700.76 billion in 2026, with a CAGR of 14.80%.
September 2026
The neuroimmunology market generated USD 41.15 billion in 2026, with prominent neuroimmunology market companies including Biogen Inc, F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi S.A.
June 2026
The global psoriasis biosimilars market size is evaluated at USD 10.46 billion in 2025 and is projected to attain around USD 29.78 billion by 2035, with a CAGR of 11.03%.
January 2025
The global immunology market size was estimated at USD 108.40 billion in 2024 and is predicted to surpass around USD 286.38 billion by 2034, with a CAGR of 10.20%.